The United States insulin delivery
devices market is expected to grow at a significant rate during the forecast
period. The increasing prevalence of diabetes due to consumption of unhealthy
eating habits comprising of junk food and high sugar-containing edible food
items and beverages leading to obesity is the major driver for the forecast
period. Adoption of a sedentary lifestyle due to long working hours, which
leaves less time left for physical activities, is giving rise to a number of
diseases.
Changing lifestyle and adopting smoking and drinking is affecting the
health condition of patients adversely. Diabetes can be cured by a permanent
treatment solution yet, but it can be controlled by taking insulin at the
required levels at the right time. Patients suffering from type-1 diabetes
require the dose of insulin to maintain the sugar level in the body as patients
are not able to produce insulin on their own and require the help of insulin
devices.
A strong economic position and well-developed healthcare infrastructure
is influencing the growth of the market. Favorable reimbursement policies and
support of the government to promote the healthcare industry and increase the
affordability of availing healthcare services are also driving factors of the
market.
United States insulin delivery devices
market is segmented into product type, distribution channel, end-user, regional
distribution, and company. Based on end-user, the market can be divided into
hospitals & clinics, home care, and others. The home care segment is
expected to witness the fastest incremental growth for the forecast period,
2023-2027.
The rise in consumer awareness regarding the adverse effects of
diabetes, along with the presence of disposable income, is accelerating the
demand for insulin delivery devices. The use of insulin devices at home saves
other expenses like visiting costs, doctor’s fees, along the time involved to
visit the hospital facility.
The major players operating in the
United States insulin delivery devices market are Medtronic USA, Inc., Roche
Diagnostics Corporation, Becton, Dickinson and Company, Novo Nordisk Inc.,
Sanofi-Aventis U.S. LLC, Eli Lilly & Company, Abbott Laboratories, Inc., B.
Braun Medical Inc., Tandem Diabetes Care, Inc., Insulet Corporation, among others.
Major companies are developing advanced technologies and launching new services
to stay competitive in the market. Other competitive strategies include mergers
& acquisitions and new service developments.
Objective of the Study:
- To analyze the historical growth of the market size of United
States insulin delivery devices market from 2017 to 2020.
- To estimate and forecast the market size of United States insulin
delivery devices market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States insulin delivery devices market
based on product type, distribution channel, end user, regional
distribution, and company.
- To identify dominant region or segment in the United States insulin
delivery devices.
- To identify drivers and challenges for United States insulin
delivery devices market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in United States insulin
delivery devices market.
- To identify and analyze the profile of leading players operating in
United States insulin delivery devices market.
- To identify key sustainable strategies adopted by market players in
United States insulin delivery devices market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers who could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufacturers,
distribution channels and presence of all major players across the globe.
TechSci
Research calculated the market size of United States insulin delivery devices market using a
bottom-up approach, wherein data for various end-user segments was recorded and
forecast for the future years. TechSci Research sourced these values from the
industry experts and company representatives and externally validated through
analyzing historical data of these product types and applications for getting
an appropriate, overall market size. Various secondary sources such as company
websites, news articles, press releases, company annual reports, investor
presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Insulin delivery devices manufacturing
companies
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums, and alliances related
to insulin delivery devices market.
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered | - Product Type
- Distribution Channel
- End User
|
|
Regional scope
|
South-West,
Mid-West, North-East
|
|
Key companies profiled
|
Medtronic USA, Inc., Roche Diagnostics Corporation, Becton,
Dickinson and Company, Novo Nordisk Inc., Sanofi-Aventis U.S. LLC, Eli Lilly
& Company, Abbott Laboratories, Inc., B. Braun Medical Inc., Tandem
Diabetes Care, Inc., Insulet Corporation.
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to regional
& segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, United States insulin
delivery devices market has been segmented into following categories, in
addition to the industry trends which have also been detailed below:
·
United States Insulin Delivery Devices Market,
By Product Type:
- Pens
- Pumps
- Pen
Needles
- Others
- United States Insulin Delivery Devices Market, By Distribution
Channel:
- Hospital
Pharmacies
- Retail
Pharmacies
- Online
- Others
- United States Insulin Delivery Devices Market, By End
User:
- Hospitals
& Clinics
- Homecare
- Others
- United States Insulin Delivery Devices Market, By Region:
- South
- West
- Mid-West
- North East
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in United States insulin delivery devices market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
United States insulin
delivery devices market is an upcoming report to be released soon. If you wish
an early delivery of this report or want to confirm the date of release, please
contact us at [email protected]